Inlight Wealth Management’s Pfizer PFE Stock Holding History

Inlight Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.37M	Sell	98,407 -278	-0.3%	-$7.27K	0.75%	26
2026 Q1	$2.77M	Sell	98,685 -1,660	-2%	-$44.2K	1.03%	21
2025 Q4	$2.5M	Sell	100,345 -5,932	-6%	-$150K	0.91%	27
2025 Q3	$2.71M	Sell	106,277 -933	-0.9%	-$23K	1.27%	21
2025 Q2	$2.6M	Sell	107,210 -4,961	-4%	-$116K	1.35%	20
2025 Q1	$2.84M	Sell	112,171 -9,788	-8%	-$256K	1.76%	19
2024 Q4	$3.24M	Buy	+121,959	New	+$3.31M	2.13%	17

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Inlight Wealth Management's PFE Position: Q2 2026 in Review

Inlight Wealth Management reduced its Pfizer (PFE) stake by 0.28% in Q2 2026, selling an estimated $7.27K and leaving 98,407 shares worth $2.37M. The position accounts for 0.75% of the portfolio, ranked #26.

Inlight Wealth Management first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.24M in Q4 2024. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Inlight Wealth Management held 98,407 shares of Pfizer worth $2.37M as of Q2 2026.
Inlight Wealth Management sold 278 Pfizer shares in Q2 2026, an estimated $7.27K.
Pfizer made up 0.75% of Inlight Wealth Management's portfolio in Q2 2026, its #26 holding.
Inlight Wealth Management first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
Inlight Wealth Management's Pfizer position peaked at $3.24M in Q4 2024.
2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Inlight Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.